Health Insurance Innovations Inc (HIIQ) Given Consensus Recommendation of “Buy” by Brokerages
Shares of Health Insurance Innovations Inc (NASDAQ:HIIQ) have been assigned a consensus recommendation of “Buy” from the twelve research firms that are covering the stock, Marketbeat Ratings reports. One equities research analyst has rated the stock with a hold rating, nine have given a buy rating and one has issued a strong buy rating on the company. The average twelve-month target price among brokerages that have issued a report on the stock in the last year is $59.38.
A number of research firms have commented on HIIQ. BidaskClub upgraded shares of Health Insurance Innovations from a “hold” rating to a “buy” rating in a research note on Friday, January 25th. ValuEngine upgraded shares of Health Insurance Innovations from a “hold” rating to a “buy” rating in a research note on Saturday, January 19th. Zacks Investment Research upgraded shares of Health Insurance Innovations from a “strong sell” rating to a “hold” rating in a research note on Friday, January 4th. B. Riley decreased their target price on shares of Health Insurance Innovations to $55.00 and set a “buy” rating on the stock in a research note on Friday, December 21st. Finally, Raymond James decreased their target price on shares of Health Insurance Innovations from $60.00 to $50.00 and set an “outperform” rating on the stock in a research note on Friday, December 14th.
In other Health Insurance Innovations news, CEO Gavin Southwell sold 65,899 shares of the stock in a transaction that occurred on Monday, February 4th. The shares were sold at an average price of $40.31, for a total transaction of $2,656,388.69. Following the completion of the sale, the chief executive officer now directly owns 609,723 shares of the company’s stock, valued at approximately $24,577,934.13. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, CFO Michael D. Hershberger sold 3,850 shares of the stock in a transaction that occurred on Friday, February 1st. The shares were sold at an average price of $40.02, for a total transaction of $154,077.00. Following the sale, the chief financial officer now directly owns 85,329 shares of the company’s stock, valued at $3,414,866.58. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 116,288 shares of company stock valued at $4,684,669. Insiders own 55.94% of the company’s stock.
NASDAQ HIIQ opened at $38.93 on Friday. Health Insurance Innovations has a 12 month low of $21.20 and a 12 month high of $63.13. The company has a market cap of $637.85 million, a price-to-earnings ratio of 32.44 and a beta of 1.81.
About Health Insurance Innovations
Health Insurance Innovations, Inc operates as a cloud-based technology platform and distributor of individual and family health insurance plans, and supplemental products in the United States. It offers short-term medical plans that provide three months of health insurance coverage with various deductible and copay levels; health benefit insurance plans, which offer daily cash benefit for hospital treatment and doctor office visits, as well as accidental injury and death or dismemberment benefits; and supplemental insurance products, including pharmacy benefit cards, dental plans, vision plans, cancer/critical illness plans, deductible and gap protection plans, and life insurance policies.
Featured Story: Day Trading
Receive News & Ratings for Health Insurance Innovations Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Health Insurance Innovations and related companies with MarketBeat.com's FREE daily email newsletter.